Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

Background : High tumor mutational burden (TMB-H) has been reported as a predictive marker to immunotherapy or prognostic marker in various tumor types. However, there has been little study of the role of TMB-H in advanced biliary tract cancer (BTC). Methods : We analyzed 119 advanced BTC patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongsik Kim MD, Hana Kim MD, Ryul Kim MD, PhD, Hyunji Jo MD, Hye Ryeon Kim MD, Joohyun Hong MD, PhD, Joon Oh Park MD, PhD, Young Suk Park MD, PhD, Seung Tae Kim MD, PhD
Format: article
Language:EN
Published: SAGE Publishing 2021
Subjects:
Online Access:https://doaj.org/article/83fd42d3d7f54068817202539c732b95
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items